Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: NDoC: NOTICE OF APPEAL to the Federal Circuit by TPL 11-4-13

I don't think I'm implying that TPL won't win in the ITC. I've said numerous times in the recent past that an ITC win will go a long way towards bringing infringer's to the table. But I think TPL is trying to get their ducks lined up for the final grand push.

You may be right with regards to 1-3, but it's all mostly speculation on everyone's parts. I will say that the per unit royalty rate is relatively low and will likely be used as the basis for any additional HTC royaties.

Share
New Message
Please login to post a reply